Stockreport

PSG Report Finds Cost Management Remains Payers' Top Goal as Coverage Strategy for New Drugs and Indications Emerges as Biggest Specialty Drug Management Challenge [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF DALLAS, April 27, 2026 BUSINESS WIRE Pharmaceutical Strategies Group ("PSG"), an EPIC company, today released its 2026 Trends in Specialty Drug Benefits Report, providi [Read more]